估计阿尔茨海默氏病的进展与细胞外囊相关的多种omics风险模型
Xiao Zhang1,2, Sanoji Wijenayake3, Shakhawat Hossain4
1Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Frontiers in aging neuroscience
|August 8, 2025
概括
这项研究引入了一种新的阿尔茨海默病 (AD) 风险评分,使用多omics数据和大脑细胞外囊泡 (EVs). 它确定了关键的EV相关基因和AD的潜在药物标,推进了个性化的风险评估和治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 是复杂的,有相互连接的途径.
- 目前的风险评分是通用的;需要个性化的因素.
- 来自大脑的细胞外囊泡 (EVs) 提供了生物标志物发现和向传递的潜力.
研究的目的:
- 开发一个个性化的阿尔茨海默病 (AD) 风险评分,使用多omics数据和与细胞外囊 (EV) 相关的基因.
- 为了确定新的AD生物标志物和治疗途径.
- 为了发现AD治疗的潜在候选药物.
主要方法:
- 从大脑组织中精选了460个EV相关基因.
- 使用考克斯回归和LASSO选择了重要的风险因素 (人口统计,转录基因).
- 在不同的奥米克水平 (转录组学,蛋白组学,DNA甲基化) 构建了三种风险模型.
- 使用基因组丰富分析 (GSEA) 和药物干扰分析评估基因特征.
主要成果:
- 确定了九个重要的EV相关基因作为AD的风险因素.
- 风险模型有效预测了高/低AD风险组.
- 在EV相关基因上训练的转录组学风险模型改善了AD分类.
- 通过GSEA发现了线粒和其他与AD相关的途径.
- 确定了四种潜在的候选药物,针对已识别的风险因素.
结论:
- 使用多omics和EV数据开发了一个新的AD风险评分模型.
- 确定了潜在的AD生物标志物和病理途径,以便进一步研究.
- 发现了阿尔茨海默病的候选药物,有可能以EV为媒介.
相关概念视频
Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668
Alzheimer's Disease: Treatment
261
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
261


